ALPN

Alpine Immune Sciences, Inc.

65.00 USD
+0.03 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Alpine Immune Sciences, Inc. stock is up 0.65% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 77.78% of the previous 8 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 10 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
18 Apr 19:41 17 May, 2024 30.00 CALL 20 1204
19 Apr 16:25 19 Apr, 2024 55.00 CALL 50 78
22 Apr 19:45 16 Aug, 2024 45.00 CALL 20 49
23 Apr 14:11 16 Aug, 2024 55.00 CALL 44 586
29 Apr 17:35 15 Nov, 2024 45.00 CALL 30 36
29 Apr 17:48 16 Aug, 2024 60.00 CALL 60 410
03 May 13:30 17 May, 2024 30.00 CALL 11 1124
03 May 13:30 17 May, 2024 40.00 CALL 26 545
03 May 13:33 17 May, 2024 40.00 CALL 25 545
03 May 13:35 17 May, 2024 40.00 CALL 50 545

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the. treatment of autoimmune and inflammatory diseases.